Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
DANIK, J. J.
and
GOVERDHAM, M.
1963.
HALOPERIDOL IN THE TREATMENT OF 120 PSYCHOTIC PATIENTS.
American Journal of Psychiatry,
Vol. 120,
Issue. 4,
p.
389.
Gerle, Bo
1964.
CLINICAL OBSERVATIONS OF THE SIDE‐EFFECTS OF HALOPERIDOL.
Acta Psychiatrica Scandinavica,
Vol. 40,
Issue. 1,
p.
65.
Kristjansen, P.
1966.
CLINICAL EVALUATION OF NEUROLEPTIC DRUG ACTION, PARTICULARY CONSIDERING BUTYROPHENONES..
Acta Psychiatrica Scandinavica,
Vol. 41,
Issue. S191,
p.
171.
JANSSEN, PAUL A.J.
1967.
Psychopharmacological Agents.
p.
199.
Gottfries, C. G.
1968.
Haloperidol och metylperidol.
Nordisk Psykiatrisk Tidsskrift,
Vol. 22,
Issue. 3,
p.
249.
Oldham, A. J.
and
Bott, M.
1971.
THE MANAGEMENT OF EXCITEMENT IN A GENERAL HOSPITAL PSYCHIATRIC WARD BY HIGH DOSAGE HALOPERIDOL.
Acta Psychiatrica Scandinavica,
Vol. 47,
Issue. 4,
p.
369.
Joy, CB
Adams, CE
Lawrie, SM
and
Joy, Claire
2001.
Cochrane Database of Systematic Reviews.
Irving, Claire B
Adams, Clive E
Lawrie, Stephen
and
Irving, Claire B
2006.
Cochrane Database of Systematic Reviews.
Higgins, Julian PT
White, Ian R
and
Wood, Angela M
2008.
Imputation methods for missing outcome data in meta-analysis of clinical trials.
Clinical Trials,
Vol. 5,
Issue. 3,
p.
225.
Adams, Clive E
Bergman, Hanna
Irving, Claire B
and
Lawrie, Stephen
2013.
Haloperidol versus placebo for schizophrenia.
Cochrane Database of Systematic Reviews,
Tardy, Magdolna
Huhn, Maximilian
Kissling, Werner
Engel, Rolf R
and
Leucht, Stefan
2014.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Cochrane Database of Systematic Reviews,
Leucht, S.
Samara, M.
Heres, S.
Patel, M. X.
Woods, S. W.
and
Davis, J. M.
2014.
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method.
Schizophrenia Bulletin,
Vol. 40,
Issue. 2,
p.
314.
eLetters
No eLetters have been published for this article.